Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuomas Mirtti

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
MRI-Targeted Prostate Biopsy Introduces Grade Inflation and OvertreatmentAbderrahim Oussama Batouche, Eugen Czeizler, Timo-Pekka Lehto, et al.
BJU International|May 4, 2012
Does patient age affect survival after radical cystectomy?David Horovitz, Polat Turker, Peter J Bostrom, et al.
The Journal of Pathology. Clinical Research|November 2, 2023
Engineering the future of 3D pathologyJonathan Tc Liu, Sarah Sl Chow, Richard Colling, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 12, 2019
Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate CancerBassem R Haddad, Andrew Erickson, Vindhya Udhane, et al.
Cells|June 10, 2023
Phosphorylation of PACSIN2 at S313 Regulates Podocyte Architecture in Coordination with N-WASPRim Bouslama, Vincent Dumont, Sonja Lindfors, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2016
Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomyKanerva Lahdensuo, Andrew Erickson, Irena Saarinen, et al.
Oncotarget|December 29, 2011
Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statinsPaula Vainio, Laura Lehtinen, Tuomas Mirtti, et al.
Human Pathology|October 3, 2012
Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomyTuomas Mirtti, Benjamin E Leiby, Junaid Abdulghani, et al.
Plos One|July 10, 2020
Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomyKevin Sandeman, Juho T Eineluoto, Joona Pohjonen, et al.
Diabetologia|May 14, 2021
Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivoSonja Lindfors, Zydrune Polianskyte-Prause, Rim Bouslama, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
MRI-Targeted Prostate Biopsy Introduces Grade Inflation and OvertreatmentAbderrahim Oussama Batouche, Eugen Czeizler, Timo-Pekka Lehto, et al.
BJU International|May 4, 2012
Does patient age affect survival after radical cystectomy?David Horovitz, Polat Turker, Peter J Bostrom, et al.
The Journal of Pathology. Clinical Research|November 2, 2023
Engineering the future of 3D pathologyJonathan Tc Liu, Sarah Sl Chow, Richard Colling, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 12, 2019
Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate CancerBassem R Haddad, Andrew Erickson, Vindhya Udhane, et al.
Cells|June 10, 2023
Phosphorylation of PACSIN2 at S313 Regulates Podocyte Architecture in Coordination with N-WASPRim Bouslama, Vincent Dumont, Sonja Lindfors, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2016
Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomyKanerva Lahdensuo, Andrew Erickson, Irena Saarinen, et al.
Oncotarget|December 29, 2011
Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statinsPaula Vainio, Laura Lehtinen, Tuomas Mirtti, et al.
Human Pathology|October 3, 2012
Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomyTuomas Mirtti, Benjamin E Leiby, Junaid Abdulghani, et al.
Plos One|July 10, 2020
Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomyKevin Sandeman, Juho T Eineluoto, Joona Pohjonen, et al.
Diabetologia|May 14, 2021
Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivoSonja Lindfors, Zydrune Polianskyte-Prause, Rim Bouslama, et al.
Pageof 13